Please login to the form below

Not currently logged in
Email:
Password:

Genentech

This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.

Roche Diagnostics’ chief heads for the exit

Roche Diagnostics’ chief heads for the exit

One such example came from Roche/Genentech earlier this month, when its global head of cancer immunotherapy development Dr Dan Chen left to join a biotech start up, IgM Biosciences. ... Genentech. 29th August 2018.

Latest news

More from news
Approximately 7 fully matching, plus 268 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 2)

    the private life sciences sector. The strategic partnerships she has forged on Immunocore’s behalf with big pharma  companies have secured vital funding and allowed the company to grow – AstraZeneca, Genentech

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    A 2016 Best Practices LLC survey of leading drug manufacturers including Genentech Baxter BioScience, GlaxoSmithKline, Boehringer Ingelheim and Teva Pharmaceutical Industries revealed that 40% already have a dedicated big data group.

  • Deal Watch - May 2017 Deal Watch - May 2017

    It has signed deals with 10 companies in the last two years including Novartis, Genentech, Sanofi, Merck &Co and Lilly.

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    Positive results from a phase Ib dose-escalation study were presented and Roche’s Genentech unit is pushing on with its 60 mg/kg dose in a phase III trial of

  • Deal Watch September 2016 Deal Watch September 2016

    Genentech will provide an $80m upfront payment, up to $830m in milestone fees plus royalties on net sales. ... 1, 000+. Hanmi / Genentech. Licence. HM95573, a selective fibrosarcoma (RAF) kinase inhibitor targeting solid tumours.

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest from PMHub

  • It's time to change the conversation

    Changing the conversation with patients. One of the earliest adopters of technology and social media to change the conversation with patients, was Genentech. ... Starting from the position of caring about the patient, Genentech created the Herceptin

  • Augmented Reality in patient communication – don’t miss out!

    Electronic Informed Consent Forms (e-ICFs) and Electronic Data Capture (EDC). In a recent well written article, Pierre Corin from Genentech discussed the drivers, advantages and possible challenges of using electronic ... References:. Pierre Corin,

  • Top 7 Trends in Pharma Marketing for 2015

    Indeed, early Jan 2015 news that  Genentech, a member of the Roche Group, are collaborating with 23andMe to analyse genomic data for Parkinson’ s disease is proof of this.

  • Random42 Scientific Communication

    Genentech. Genzyme. Gilead. Grunenthal. GlaxoSmithKline. HCA Healthcare. Heron Therapeutics. Ignyta. Ironwood.

  • Random42 Scientific Communication

    Genentech. Genzyme. Gilead. Grunenthal. GlaxoSmithKline. HCA Healthcare. Heron Therapeutics. Ignyta. Ironwood.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics